Early knee OA appears to be a stable condition, with a low proportion of knees showing worsening structural damage or symptom progression over time.

GEA is effective and safe for reducing OA symptoms among patients with knee OA that is refractory to conservative therapy.

Patients with chronic pain treated with the novel FAST SCS systems may achieve significant and durable pain relief for up to 12 months of follow-up.

Faced with rising cases of bird flu virus being detected in raw milk in California, the USDA announced it would mandate testing for the virus in milk nationwide.

Patients, especially women, with PTSD in low-income areas were more likely to rapidly reduce or discontinue opioids than those in high-income areas.

Neuropathic pain is common in spondyloarthritis, particularly among women and those with comorbid obesity or fibromyalgia.

The FDA has granted Orphan Drug designation to BRC-002 (cannabidiol botanical extract) for the treatment of complex regional pain syndrome.

Many general practitioners prescribe antibiotics for suspected CAP even when chest radiograph results are negative.

Among patients with poststroke pain, scrambler therapy may lead to a reduction in pain, but its long-term effect is unclear.

TAP block provided no clinically meaningful difference vs placebo in pain relief following minimally invasive abdominal surgery.

Continuous adductor canal block resulted in better outcomes and less need for opioids than epidural analgesia after inpatient total knee arthroplasty.

Globally, antibiotic consumption increased 16.3% from 2016 to 2023 and is projected to continue increasing through 2030.